Apogee Therapeutics, Inc. — SCHEDULE 13D/A Filings
3 SCHEDULE 13D/A filings on record
This page lists all SCHEDULE 13D/A filings submitted to the SEC by Apogee Therapeutics, Inc. (APGE), sorted by most recent first. Each row links to the full filing on EdgarLookup. Apogee Therapeutics, Inc. has filed 3 SCHEDULE 13D/A documents with the SEC since 2023. To view all SEC filings by Apogee Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13D/A | — | 0001104659-26-036265 | Mar 27, 2026 | — |
| SCHEDULE 13D/A | — | 0001104659-26-005916 | Jan 22, 2026 | — |
| SCHEDULE 13D/A | — | 0001104659-25-099401 | Oct 14, 2025 | — |